Interestingly, multiple regression showed that plasma ghrelin changes were mainly due to changes of androgen levels rather than improved insulin sensitivity in antiandrogen flutamide-treated subjects with PCOS [205]. This evidence concerns the gene GHRL and polycystic ovary syndrome.